April 16, 2026
The former Tokyo Biochemical Research Foundation (hereinafter referred to as "former TBRF") was established in 1960 by Professor Morizo Ishidate of the then Faculty of Pharmaceutical Sciences of the University of Tokyo and Juzo Ueno, then President of Chugai Pharmaceutical Co. Since then, over the 66 years, it had contributed to the advancement and development of medical and pharmaceutical sciences, mainly through the operation of our research centers and research grants in Japan and other Asian countries. In April 2019, the Institute merged with the former Chugai Academy for Advanced Oncology (hereafter referred to as “former CHAAO”). On April 1, 2022, on the occasion of the 60th anniversary of its foundation, the former TBRF changed its name to Chugai Foundation for Innovative Drug Discovery Science (hereinafter referred to as " C-FINDs ") and have continued to evolve in response to the changing times.
C-FINDs has three new basic principles: "top-level science," "human resource development and education for young researchers," and "a global perspective. The purpose of C-FINDs is to "promote research in the field of drug discovery and drug treatment by supporting and encouraging basic and clinical research in this field, and by fostering researchers and promoting international exchange in research activities.
In recent years, the environment surrounding drug discovery and life science research has undergone significant changes. As national policies advance efforts to strengthen the drug discovery ecosystem, the importance of supporting basic research in drug discovery and fostering research talent has become even more pronounced. Furthermore, economic conditions such as rising prices and the depreciation of the yen have created challenges, requiring us to address the declining real value of research grants.
In light of these circumstances, C-FINDs will undertake an expansion of its programs—centered on academic research grants and overseas study fellowships—beginning in fiscal year 2026. With an increased endowment generously provided by our founding donor, Chugai Pharmaceutical Co., Ltd., we will further strengthen our support for basic research across diverse fields of life sciences that will shape the future of drug discovery, as well as our efforts to cultivate the next generation of research talent. Through these initiatives, we remain committed to further enhancing our activities in alignment with C-FINDs’ mission.
Finally, I would like to express my sincere appreciation for the warm understanding and support of all those who have contributed to the development and promotion of the Foundation's activities. C-FINDs will continue to build on the traditions of the past, while focusing its future activities on the promotion of original research in the life science field related to drug treatment and new pharmaceuticals, and the fostering of ambitious young researchers, which will open up a new era. We will continue to strive for future-oriented initiatives, and we look forward to your continued guidance and encouragement in the business activities of C-FINDs.